Takeshi Kiyoi Selected Research

3- methyl- 5- (1- methyl- 2- pyrrolidinyl)isoxazole

3/2016

The α4β2 nicotinic acetylcholine receptor modulates autism-like behavioral and motor abnormalities in pentylenetetrazol-kindled mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takeshi Kiyoi Research Topics

Disease

5	Neoplasms (Cancer) 12/2021 - 03/2015
4	Rheumatoid Arthritis 04/2018 - 01/2015
3	Body Weight (Weight, Body) 05/2022 - 04/2018
3	Experimental Arthritis 04/2018 - 01/2015
2	Inflammation (Inflammations) 04/2018 - 11/2017
1	Hyperlipidemias (Hyperlipidemia) 05/2022
1	Insulin Resistance 05/2022
1	Maternal Obesity 05/2022
1	Weight Gain 05/2022
1	Dyslipidemias (Dyslipidemia) 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 12/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Colonic Neoplasms (Colon Cancer) 11/2020
1	Carcinogenesis 11/2020
1	Vascular Remodeling 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Vascular Diseases (Vascular Disease) 01/2020
1	Atherosclerosis 01/2020
1	Vascular System Injuries 01/2020
1	Neointima 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Arthritis (Polyarthritis) 03/2017
1	Epilepsy (Aura) 03/2016
1	Mental Disorders (Mental Disorder) 03/2016
1	Autistic Disorder (Autism) 03/2016
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 03/2016
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2016
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2016
1	Colitis 03/2015
1	Stomatitis 03/2015

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2016
4	CytokinesIBA 11/2020 - 01/2015
3	Calcium Release Activated Calcium ChannelsIBA 04/2018 - 01/2015
2	CholesterolIBA 05/2022 - 11/2017
2	Glucose (Dextrose)FDA LinkGeneric 05/2022 - 01/2022
2	Dextran SulfateIBA 11/2020 - 03/2015
2	Small Interfering RNA (siRNA)IBA 03/2017 - 01/2015
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 03/2016 - 03/2015
1	Dietary Fats (Dietary Fat)IBA 05/2022
1	Triglycerides (Triacylglycerol)IBA 05/2022
1	Insulin (Novolin)FDA Link 01/2022
1	gallium 68 PSMA-11IBA 12/2021
1	Conditioned Culture MediaIBA 12/2021
1	CollagenIBA 12/2021
1	GelsIBA 12/2021
1	AntigensIBA 12/2021
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2021
1	UbiquitinIBA 01/2021
1	Monomeric GTP-Binding ProteinsIBA 01/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	Ligases (Synthetase)IBA 01/2021
1	Interleukin Receptors (Interleukin Receptor)IBA 11/2020
1	AzoxymethaneIBA 11/2020
1	ChemokinesIBA 11/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2020
1	Monocyte Chemoattractant ProteinsIBA 11/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2020
1	Interleukin-6 (Interleukin 6)IBA 11/2020
1	HydrogenIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2019
1	IntegrinsIBA 01/2019
1	Immunoglobulin G (IgG)IBA 04/2018
1	4- methyl- 4'- (3,5- bis(trifluoromethyl)- 1H- pyrazol- 1- yl)- 1,2,3- thiadiazole- 5- carboxanilideIBA 04/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2017
1	CalciumIBA 03/2017
1	Pentylenetetrazole (Metrazol)IBA 03/2016
1	3- methyl- 5- (1- methyl- 2- pyrrolidinyl)isoxazoleIBA 03/2016
1	thiobarbituric acidIBA 03/2015
1	Pharmaceutical PreparationsIBA 03/2015
1	Peroxidase (Myeloperoxidase)IBA 03/2015
1	AntioxidantsIBA 03/2015
1	EdaravoneIBA 03/2015
1	Tropisetron (Navoban)IBA 03/2015
1	PNU-282987IBA 03/2015
1	methyllycaconitineIBA 03/2015

Therapy/Procedure

1	Fat-Restricted Diet (Diet, Fat Restricted) 01/2022
1	Castration 12/2021
1	Transjugular Intrahepatic Portasystemic Shunt 03/2015
1	Radiotherapy 03/2015